跳至主要内容
临床试验/NCT06856941
NCT06856941招募中不适用

Cerebello-spinal Direct Current Stimulation Associated with Treadmill Gait Training in Functional Mobility in Patients with Parkinsons Disease

Universidade Federal de Pernambuco1 个研究点 分布在 1 个国家目标入组 66 人开始时间: 2024年5月9日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
66
试验地点
1
主要终点
Timed Up and Go

研究概览

简要总结

Parkinsons disease is a progressive neurological disorder marked by a decline in the efficacy of dopaminergic synapses in the nigrostriatal pathway, causing motor disturbances. Resting tremor, bradykinesia, and muscle rigidity are the most prominent motor features. These factors result in gait impairments, including slowness and freezing. The primary treatment for the disease is medication. However, while medication does reduce motor symptoms, prolonged usage may lead to an increase of dyskinesias and a worsening of a patients clinical condition. Thus, alternative therapies, such as cerebellospinal direct current stimulation (csDCS), have gained popularity. Studies suggest that csDCS may be an effective approach to mitigate gait disorders in this patient population. Kinesiotherapy is an established therapeutic method that has been demonstrated to promote functional mobility and improve gait. To date, the combination of kinesiotherapy and csDCS has not been tested, thus the purpose of this study is to evaluate the effectiveness of this combined therapy for enhancing functional mobility in Parkinsons disease patients. The goal of this study is to assess the efficacy of blending csDCS and kinesiotherapy for improving patients functional mobility in Parkinsons disease. Two groups of volunteers will be assigned: i) actual csDCS + kinesiotherapy, and ii) sham csDCS + kinesiotherapy. The full procedure involves 10 therapy sessions conducted across two weeks.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
40 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •a clinical diagnosis of PD provided by a neurologist
  • •regular dopaminergic drug treatment (at least three months of use)
  • •aged 40 years or over
  • •staging I to IV on the modified Hoehn and Yahr scale

排除标准

  • •other neurological disorders, postural hypotension, vestibular, musculoskeletal or visual disorders that compromise performance in the proposed tests
  • •other osteoarticular diseases in the lower limbs that interfere with performance and locomotion
  • •a Montreal Cognitive Assessment (MoCA) score of less than 21 points
  • •have undergone previous surgery for PD

研究组 & 干预措施

csDCS

Active Comparator

干预措施: cerebello-spinal direct current stimulation (Device)

csDCS sham

Sham Comparator

干预措施: sham cerebello-spinal direct current stimulation (Device)

结局指标

主要结局

Timed Up and Go

时间窗: From enrollment to the end of treatment at 4 weeks

For the TUG, the time taken by the patient to perform a task involving standing up from a chair, walking, and sitting back down is measured. The test begins with the patient seated in a chair with their back against the backrest. Upon request, the patient stands up, walks three meters at their fastest yet safe pace, turns around, returns to the chair, and sits down. Shorter times in completing this task indicate better functional mobility. Three repetitions of the test were recorded, and for analysis purposes, the average of the repetitions was used.

次要结局

  • Five times sit to stand test(From enrollment to the end of treatment at 4 weeks)
  • Mini balance evaluation system test(From enrollment to the end of treatment at 4 weeks)
  • Unified Parkinson Disease Rating Scale-II and Scale-III(From enrollment to the end of treatment at 4 weeks)
  • Freezing of gait questionnaire(From enrollment to the end of treatment at 4 weeks)
  • Six minute walking test(From enrollment to the end of treatment at 4 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Kátia Monte-Silva

Doctor professor

Universidade Federal de Pernambuco

研究点 (1)

Loading locations...

相似试验

CsDCS on Functional Mobility in Parkinsons Disease | 临床试验